Extracellular adenosine 5′-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors

被引:17
作者
Caraccio, N
Monzani, F
Santini, E
Cuccato, S
Ferrari, D
Callegari, MG
Gulinelli, S
Pizzirani, C
Di Virgilio, F
Ferrannini, E
Solini, A
机构
[1] Univ Pisa, Dept Internal Med, Sect Internal Med 3, I-56100 Pisa, Italy
[2] Univ Ferrara, Sect Gen Pathol, Interdisciplinary Ctr Study Inflammat, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy
关键词
D O I
10.1210/en.2004-1527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the presence of P2 receptors (P2Rs) in human thyrocytes and their possible involvement in the modulation of cytokine release. P2Rs expression was assessed by RT-PCR and, when possible, by immunoblotting. Human primary thyrocytes express the mRNA for the following P2X and P2Y subtypes: P2X(3), P2X(5), P2X(6), P2X(7), and P2Y(1), P2Y(2), P2Y(4), and P2Y(11). Stimulation with extracellular nucleotides of fura-2-loaded thyrocytes triggered an intracellular Ca2+ signal, suggesting expression of functional receptors. Thyrocytes spontaneously released the proinflammatory cytokine IL-6. The ATP-hydrolyzing enzyme apyrase reduced basal IL-6 release, whereas extracellular ATP dose-dependently increased IL-6 secretion. Uridine 5'-triphosphate was also an effective stimulus, whereas benzoyl-ATP was ineffective, suggesting a P2Y- rather than P2X-modulated response. Finally, TSH reduced both the intracellular Ca2+ ([Ca2+](i)) rise and IL-6 release triggered by P2Rs stimulation. In conclusion, we provide functional, pharmacological, and biochemical evidence that human primary thyrocytes express P2YR and P2XR subtypes, coupled to increases in ([Ca2+](i)) and secretion of IL-6. P2R-dependent modulation of IL-6 release from human thyrocytes suggests a novel mechanism whereby an inflammatory and/or immune-mediated damage can be initiated and amplified in the thyroid.
引用
收藏
页码:3172 / 3178
页数:7
相关论文
共 37 条
  • [1] Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family
    Abbracchio, MP
    Boeynaems, JM
    Barnard, EA
    Boyer, JL
    Kennedy, C
    Miras-Portugal, MT
    King, BF
    Gachet, C
    Jacobson, KA
    Weisman, GA
    Burnstock, G
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (02) : 52 - 55
  • [2] Cytokines in thyroid autoimmunity
    Ajjan, RA
    Weetman, AP
    [J]. AUTOIMMUNITY, 2003, 36 (6-7) : 351 - 359
  • [3] INTERLEUKIN-6 AND THE THYROID
    BARTALENA, L
    BROGIONI, S
    GRASSO, L
    MARTINO, E
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 132 (04) : 386 - 393
  • [4] Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase
    Beigi, R
    Kobatake, E
    Aizawa, M
    Dubyak, GR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 276 (01): : C267 - C278
  • [5] Induced illness in interleukin-6 (IL-6) knock-out mice: A causal role of IL-6 in the development of the low 3,5,3'-triiodothyronine syndrome
    Boelen, A
    Maas, MAW
    Lowik, CWGM
    Platvoet, MC
    Wiersinga, WM
    [J]. ENDOCRINOLOGY, 1996, 137 (12) : 5250 - 5254
  • [6] Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness
    Davies, PH
    Black, EG
    Sheppard, MC
    Franklyn, JA
    [J]. CLINICAL ENDOCRINOLOGY, 1996, 44 (02) : 199 - 205
  • [7] Di Virgilio Francesco, 2001, Trends in Pharmacological Sciences, V22, P5
  • [8] Mechanisms of P2 receptor-evoked DNA synthesis in thyroid FRTL-5 cells
    Ekokoski, E
    Webb, TE
    Simon, J
    Törnquist, K
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 187 (02) : 166 - 175
  • [9] Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin
    Ferrari, D
    Chiozzi, P
    Falzoni, S
    Hanau, S
    DiVirgilio, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) : 579 - 582
  • [10] Ferrari D, 1997, J IMMUNOL, V159, P1451